State MO
Clinical Trials in Missouri
Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.
Top Conditions in Missouri
NCT06122779 Phase 2
Recruiting
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in ...
Condition
Heart Failure
Enrollment
208 pts
Location
United States, Argentina, Canada
Sponsor
Bristol-Myers Squibb
NCT07020273 N/A
Recruiting
CONNECT Cancer Survivors With Tobacco Treatment
Condition
Tobacco Use
Enrollment
5,000 pts
Location
United States
Sponsor
Washington University School o
NCT07110246 Phase 2
Recruiting
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
Condition
BRAF V600 Mutation
Enrollment
96 pts
Location
United States
Sponsor
University of California, San
NCT06013046 N/A
Recruiting
Wheelchair User Physical Activity Training Intervention to Enhance Cardiometabol...
Condition
Physical Disability
Enrollment
108 pts
Location
United States
Sponsor
Washington University School o
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05010603 N/A
Recruiting
Late Onset Alzheimer's Disease
Condition
Alzheimer Disease
Enrollment
10,000 pts
Location
United States
Sponsor
Columbia University
NCT04205968 Phase 2
Recruiting
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Condition
Metastatic Small Intestinal Adenocarcinoma
Enrollment
94 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT05629546 Phase 1
Recruiting
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Me...
Condition
Advanced Melanoma
Enrollment
33 pts
Location
United States
Sponsor
Washington University School o
NCT05285527 N/A
Recruiting
MiSight 1 Day Safety Post-Approval Study
Condition
Myopia
Enrollment
2,400 pts
Location
United States, Canada
Sponsor
CooperVision, Inc.
NCT07140913 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatmen...
Condition
Mania
Enrollment
424 pts
Location
United States, Argentina, Bulgaria
Sponsor
Bristol-Myers Squibb
NCT05826457 N/A
Recruiting
North American Prodromal Synucleinopathy Consortium Stage 2
Condition
REM Sleep Behavior Disorder
Enrollment
500 pts
Location
United States, Canada
Sponsor
Washington University School o
NCT04772131 N/A
Recruiting
Desara ® One Single Incision Sling 522 Study
Condition
Stress Urinary Incontinence
Enrollment
300 pts
Location
United States
Sponsor
Caldera Medical, Inc.
NCT06940141 Phase 2
Recruiting
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT As...
Condition
Asthma Acute
Enrollment
160 pts
Location
United States, Argentina, Australia
Sponsor
Connect Biopharm LLC
NCT04748601 Phase 4
Recruiting
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Condition
Migraine Disorders
Enrollment
132 pts
Location
United States
Sponsor
Upsher-Smith Laboratories
NCT06109272 Phase 2, Phase 3
Recruiting
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Li...
Condition
Hepatocellular Carcinoma
Enrollment
660 pts
Location
United States, France, Italy
Sponsor
AbbVie
NCT07217327 N/A
Recruiting
The DistaSense VITALS Study
Condition
Detection of Heart Rate and Respiratory Rate
Enrollment
20 pts
Location
United States
Sponsor
Life Detection Technologies
NCT06809179 Phase 2
Recruiting
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Do...
Condition
Social Anxiety Disorder
Enrollment
60 pts
Location
United States
Sponsor
VistaGen Therapeutics, Inc.
NCT05965245 N/A
Recruiting
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Condition
Depression
Enrollment
278 pts
Location
United States, Uganda
Sponsor
Washington University School o
NCT04712877 N/A
Recruiting
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patien...
Condition
NSCLC
Enrollment
1,000 pts
Location
United States
Sponsor
Lung Cancer Mutation Consortiu
NCT06911112 Phase 3
Recruiting
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as a...
Condition
Major Depressive Disorder
Enrollment
200 pts
Location
United States
Sponsor
Neurocrine Biosciences
NCT07382167 Phase 3
Recruiting
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopa...
Condition
Chronic Idiopathic Constipation (CIC)
Enrollment
692 pts
Location
United States
Sponsor
Ardelyx
NCT06958536 Phase 2
Recruiting
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's...
Condition
Crohn's Disease
Enrollment
99 pts
Location
United States, Australia, Belgium
Sponsor
Sanofi
NCT06966401 Phase 3
Recruiting
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjun...
Condition
Major Depressive Disorder
Enrollment
600 pts
Location
United States
Sponsor
Neurocrine Biosciences
NCT06290128 Phase 3
Recruiting
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inf...
Condition
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Enrollment
140 pts
Location
United States, Argentina, Belgium
Sponsor
Sanofi
NCT07007065 Phase 3
Recruiting
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
561 pts
Location
United States, Austria, Belgium
Sponsor
AbbVie